Effects of mechano-electric feedback: Potential arrhythmogenic influence in patients with congestive heart failure

Cardiovascular Research

Volumn 32, Issue 1, 1996, Pages 44-51

  Reiter, Michael J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Arrhythmia; Heart failure; Mechano electrical feedback; Stretch

Indexed keywords

ANTIARRHYTHMIC AGENT; ENALAPRIL; HYDRALAZINE; NITRIC ACID DERIVATIVE;

CONGESTIVE HEART FAILURE; FEEDBACK SYSTEM; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; HEART CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ARRHYTHMIA; FEEDBACK; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL CONTRACTION; SIGNAL TRANSDUCTION;

EID: 0030176794     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(95)00082-8     Document Type: Review

References (44)

1. [1] Kjekshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol 1990;65:421-481.
2. [2] Gradman A, Deedwania P, Cody R, Massie B. Packer M, Pitt B. Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1989;14:564-570.
3. [3] Holmes J, Kubo SH, Cody RJ, Kligfield P. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985;55:146-151.
4. [4] Spielman SR, Schwanz JS, McCarthy DM, Horowitz LN, Greenspan AM, Sadowski LM, Josephson ME, Waxman HL. Predictors of the success or failure of medical therapy in patients with chronic recurrent sustained ventricular tachycardia: a discriminate analysis. J Am Coll Cardiol 1983;1:401-408.
5. [5] de Paola AA, Horowitz LN, Morganroth J, Senior S, Spielman SR, Greenspan AM, Kay HR. Influence of left ventricular dysfunction on flecainide therapy. J Am Coll Cardiol 1987;9:163-168.
6. [6] Slater W, Lampert S, Podrid PJ, Lown B. Clinical predictors of arrhythmia worsening by antiarrhythmic drugs. Am J Cardiol 1988;61:349-353.
7. [7] Lab MJ. Mechanically dependent changes in action potentials recorded from the intact frog ventricle. Circ Res 1978;42:519-528.
8. [8] Dean JW, Lab MJ. Arrhythmia in heart failure: role of mechanically induced changes in electrophysiology. Lancet 1989(June);10:1309-1311.
9. [9] Taggart P, Sutton P, Lab M. Interaction between ventricular loading and repolarisation: relevance to arrhythmogenesis. Br Heart J 1992;67:213-215.
10. [10] Allessie MA, Bonke FIM, Schopman FJG. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac-tissue without the involvement of an anatomic obstacle. Circ Res 1977;41:9-18.
11. [11] Stacy GP Jr, Jobe RL, Taylor K, Hansen DE. Stretch-induced depolarizations as a trigger of arrhythmias in isolated canine left ventricles. Am J Physiol 1992;263(Heart Circ Physiol 32):H613-H621.
12. [12] Franz MR, Cima R, Wang D, Profitt D, Kurz R. Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation 1992;86:968-978.
13. [13] Levine JH, Guarnieri T, Kadish AH, White RI, Calkins H, Kan JS. Changes in myocardial repolarization in patients undergoing balloon valvuloplasty for congenital pulmonary stenosis: evidence for contraction-excitation feedback in humans. Circulation 1988;77:70-77.
14. [14] Hansen DE. Mechanoelectrical feedback effects of altering preload, afterload, and ventricular shortening. Am J Physiol 1993;264(Heart Circ Physiol 33):H423-H432.
15. [15] Lerman BB, Burkhoff D, Yue DT, Sagawa K. Mechanoelectrical feedback: independent role of preload and contractility in modulation of canine ventricular excitability. J Clin Invest 1985;76:1843-1850.
16. [16] Dean JW, Lab MJ. Effect of changes in load on monophasic action potential and segment length of pig heart in situ. Cardiovasc Res 1989;23:887-896.
17. [17] Reiter MJ, Synhorst DP, Mann DE. Electrophysiologic effects of acute ventricular dilatation in the isolated rabbit heart. Circ Res 1988;62:554-562.
18. [18] Taggart P, Sutton PMI, Treasure T, Lab M, O'Brien W, Runnalls M, Swanton RH, Emanuel RW. Monophasic action potentials at discontinuation of cardiopulmonary bypass: evidence for contraction excitation feedback in man. Circulation 1988;77:1266-1275.
19. [19] Taggart P, Sutton P, Lab M, Runnalls M, O'Brien W, Treasure T. Effect of abrupt changes in ventricular loading on repolarization induced by transient aortic occlusion inhumans. Am J Physiol 1992;263(Heart Circ Physiol 32):H816-H823.
20. [20] Bashir Y, Sneddon JF, O'Nunain S, Paul VE, Gibson S, Ward DE, Camm AJ. Comparative electrophysiological effects of captopril or hydralazine combined with nitrate in patients with left ventricular dysfunction and inducible ventricular tachycardia. Br Heart J 1992;67:355-360.
21. [21] Reiter MJ, Zetelaki Z, Kirchhof CJ, Allessie MA. Decrease in ventricular refractoriness due to dilatation is cycle length dependent. Circulation 1994;90:1-519.
22. [22] Halperin BD, Adler SW, Mann DE, Reiter MJ. Mechanical correlates of contraction-excitation feedback during acute ventricular dilation. Cardiovasc Res 1993;27:1084-1087.
23. [23] Bustamante JO, Ruknudin A, Sachs F. Stretch-activated channels in heart cells: relevence to cardiac hypertrophy. J Cardiovasc Pharmacol 1991;17(Suppl 2):S110-S113.
24. [24] Lab MJ, Allen DG, Orchrad CH. The effects of shortening on myoplasmic calcium concentration and on the action potential in mammalian ventricular muscle. Circ Res 1984;55:825-829.
25. 2+-activated potassium channels. J Am Coll Cardiol 1994(February):88A(Abstr.).
26. [26] Wester PO, Dyckner T. Intracellular electrolytes in cardiac failure. Acta Med Scand Suppl 1986;707:33-36.
27. [27] Dargie HJ, Cleland JG, Leckie BJ, Inglis CG, East BW, Ford I. Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic congestive heart failure. Circulation 1987;(Suppl IV)75:IV98-107.
28. [28] Reiter MJ, Mann DE, Williams GR. Interaction of hypokalemia and ventricular dilatation in isolated rabbit hearts. Am J Physiol 1993;265(Heart Circ Physiol 34):H1544-H1550.
29. [29] Kaseda S, Zipes DP. Contraction-excitation feedback in the atria: a cause of changes in refractoriness. J Am Coll Cardiol 1988;11:1327-1336.
30. [30] Klein LS, Miles WM, Zipes DP. Effect of atrioventricular interval during pacing or reciprocating tachycardia on atrial size, pressure, and refractory period. Circulation 1990;82:60-68.
31. [31] Calkins H, El-Atassi R, Kalbfleisch S, Langberg J, Morady F. Effects of an acute increase in atrial pressure on atrial refractoriness in humans. PACE 1992;15:1674-1680.
32. [32] Solti F, Vecsey T, Kekesi V, Juhasz-Nagy A. The effect of atrial dilatation on the genesis of atrial arrhythmias. Cardiovasc Res 1989;23:882-886.
33. [33] Reiter MJ, Zetelaki Z, Kirchhof CJH, Boersma L, Allessie MA. Interaction of acute ventricular dilatation and d-sotalol during sustained reentrant ventricular tachycardia around a fixed obstacle. Circulation 1994;89:423-431.
34. [34] Ravelli F, Disertori M, Cozzi F, Antolini R, Allessie MA. Ventricular beats induce variations in cycle length of rapid (type II) atrial flutter in man. Evidence of leading circle reentry. Circulation 1994;89:2107-2116.
35. [35] Brugada J, Boersma L, Kirchhof C, Brugada P, Havenith M, Wellens HJ, Allessie M. Double-wave reentry as a mechanism of acceleration of ventricular tachycardia. Circulation 1990;81:1633-1643.
36. [36] Ravid S, Podrid PJ, Lampert S, Lown B. Congestive heart failure induced by six of the newer antiarrhythmic drugs. J Am Coll Cardiol 1989;14:1326-1330.
37. [37] Carlson MD, Schoenfeld MH, Garan H, Choong CY, Davidoff R, Weyman AE, Ruskin JN, Fifer MA. Programmed ventricular stimulation in patients with left ventricular dysfunction and ventricular tachycardia: effects of acute hemodynamic improvement due to nitroprusside. J Am Coll Cardiol 1989;14:1744-1752.
38. [38] Kulick D, Bhandari AK, Hong R, Petersen R, Leon C, Rahimtoola SH. Effect of acute hemodynamic decompensation on electrical inducibility of ventricular arrhythmias in patients with dilated cardiomyopathy and complex non-sustained ventricular arrhythmias. Am Heart J 1990;119:878-883.
39. [39] Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative study. N Engl J Med 1986;314:1547-1552.
40. [40] The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
41. [41] Fletcher R, Johnson G, Cohn J and VHEFT VA Cooperative Study Group. Vasodilator improvement of mortality in CHF is dependent on the presence of ventricular arrhythmia. Circulation 1988;78:II-347(Abst.).
42. [42] Fletcher R, Cintron G, Johnson G, Cohn JN. VA Cooperative Study. Enalapril decreases ventricular tachycardia in heart failure: VHeFT II. Circulation 1991 84:II-310 (Abst.).
43. [43] Cleland JGF, Dargie HJ, Hodsman GP, Ball SG, Robertson JIS, Morton JJ, East BW, Robertson I, Murray GD, Gillen G. Captopril in heart failure - a double-blind controlled trial. Br Heart J 1984;52:530-535.
44. [44] The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988;259:539-544.